During development, homeostasis, tumor growth, or ischemia, cellular oxygen levels are often insufficient to meet physiological demands. The human hypoxia-inducible factor (HIF-1) implements most of the critical transcriptional changes that mediate adaptation to hypoxia. Pharmaceuticals that modulate HIF activity hold great therapeutic potential for preventing cancer growth and for mitigating the effects of cardiovascular disease. The long-term goals of this project are to identify and characterize the molecules and pathways that control HIF activity. The central hypothesis guiding these studies is that cells employ multiple strategies to monitor oxygen levels and keep HIF-1 activity """"""""in check"""""""". Our experimental strategy employs Caenorhabditis elegans, a powerful system for gene discovery and characterization of genetic networks. This innovative approach will complement and extend the wealth of molecular and biochemical studies that have investigated the regulation of HIF in cancer cell lines. The C. elegans hif-1, egl-9 and vhl-1 genes are orthologous to the genes encoding the Hlp alpha subunit, the EGLN/ PHD / HPH prolyl hydroxylase, and the VHL tumor suppressor, respectively. In preliminary studies, we have shown that EGL-9 inhibits HIF-1 function via two distinct mechanisms: (i) the well-described EGL-9 / VHL-1 pathway for oxygen-dependent degradation of HIF-1, and (ii) a VHL-1-independent pathway for inhibition of HIF-1 transcriptional activity that remains to be characterized. Using forward genetic strategies, we have identified mutations in other genes (termed """"""""rhy"""""""", regulators of hypoxia-inducible factor) that appear to act in concert with EGL-9 to regulate HIF-1 activity. The objective of this proposal is to identify and characterize genes and cellular networks that inhibit HIF transcriptional activity, independent of the EGL-9 /VHL-1 pathway for regulating HIF protein levels. Towards this goal, we propose three specific aims: (1) Characterize the molecular mechanisms by which EGL-9 inhibits HIF-1 activity, independent of VHL-1;(2) Identify and characterize genes that act in concert with EGL-9 or in parallel pathways to attenuate HIF-1 activity;(3) Define RHY-1 topology and elucidate the role of RHY-1 in HIF-1 regulatory networks. These studies will provide important insights to HIF regulatory networks and will advance the development of therapies to treat cancer and heart disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM078424-04
Application #
7837594
Study Section
Molecular Genetics B Study Section (MGB)
Program Officer
Maas, Stefan
Project Start
2007-08-01
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2012-05-31
Support Year
4
Fiscal Year
2010
Total Cost
$243,060
Indirect Cost
Name
Iowa State University
Department
Genetics
Type
Schools of Arts and Sciences
DUNS #
005309844
City
Ames
State
IA
Country
United States
Zip Code
50011
Saldanha, Jenifer N; Parashar, Archana; Pandey, Santosh et al. (2013) Multiparameter behavioral analyses provide insights to mechanisms of cyanide resistance in Caenorhabditis elegans. Toxicol Sci 135:156-68
Park, Eun Chan; Ghose, Piya; Shao, Zhiyong et al. (2012) Hypoxia regulates glutamate receptor trafficking through an HIF-independent mechanism. EMBO J 31:1379-93
Powell-Coffman, Jo Anne (2010) Hypoxia signaling and resistance in C. elegans. Trends Endocrinol Metab 21:435-40
Shao, Zhiyong; Zhang, Yi; Ye, Qi et al. (2010) C. elegans SWAN-1 Binds to EGL-9 and regulates HIF-1-mediated resistance to the bacterial pathogen Pseudomonas aeruginosa PAO1. PLoS Pathog 6:e1001075
Powell-Coffman, Jo Anne; Coffman, Clark R (2010) Apoptosis: Lack of oxygen aids cell survival. Nature 465:554-5
Zhang, Yi; Shao, Zhiyong; Zhai, Zhiwei et al. (2009) The HIF-1 hypoxia-inducible factor modulates lifespan in C. elegans. PLoS One 4:e6348
Shao, Zhiyong; Zhang, Yi; Powell-Coffman, Jo Anne (2009) Two distinct roles for EGL-9 in the regulation of HIF-1-mediated gene expression in Caenorhabditis elegans. Genetics 183:821-9